Among the most successful fund investment fields, there are Biopharma, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Acticor Biotech. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
The fund is generally included in less than 2 deals every year. The top activity for fund was in 2018. Deals in the range of 10 - 50 millions dollars are the general things for fund.
The usual cause for the fund is to invest in rounds with 5 partakers. The meaningful sponsors for the fund in investment in the same round are Newton Biocapital, Mirae Asset Global Investments, CapDecisif. In the next rounds fund is usually obtained by Newton Biocapital, Go Capital, CapDecisif.
Related Funds
Fund Name | Location |
Adelie | France, Ile-de-France, Paris |
Birchaven Group | - |
BVGroup | Bern, Gümligen, Switzerland |
Clare Island Media GmbH | - |
Crocker Mountain Capital | - |
DCVC Opportunity | - |
Dongzhao Shanghai Group | - |
Flux Capital | California, Los Angeles, United States |
i2i Ventures | Islamabad, Pakistan |
Kodak | New York, Rochester, United States |
Ming Bioventures | China, Jiangsu, Suzhou |
National Association of Broadcasters | - |
Playground Global | California, Palo Alto, United States |
Powe Capital Management | England, London, United Kingdom |
Prophetic Ventures | India, Maharashtra, Mumbai |
Trinity Health | Livonia, Michigan, United States |
Whittvest Holdings | - |
Zhejiang Zhuji Intelligent Security Industry Fund | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Acticor Biotech | $8M | 06 Nov 2019 | Ile-de-France |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Acticor Biotech | $8M | 06 Nov 2019 | Ile-de-France |